Insulin degludec Subcutaneous and Recombinate recombinant
Determining the interaction of Insulin degludec Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Recombivax
- Insulin degludec Subcutaneous-Recombivax HB
- Insulin degludec Subcutaneous-Recombivax HB Adult
- Insulin degludec Subcutaneous-Recombivax HB Dialysis Formulation
- Insulin degludec Subcutaneous-Recombivax HB Pediatric/Adolescent
- Insulin degludec Subcutaneous-Recort Plus
- Recombinate recombinant-Insulin detemir
- Recombinate recombinant-Insulin Detemir (Cartridges and Prefilled Syringes)
- Recombinate recombinant-Insulin Detemir (Vials)
- Recombinate recombinant-Insulin detemir Subcutaneous
- Recombinate recombinant-Insulin glargine
- Recombinate recombinant-Insulin Glargine (U-100) Cartridge Systems and Pens